About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [2,288 citations: 1–100 of 2,007 articles]

Articles published in International Journal of Alzheimer’s Disease have been cited 2,288 times. The following is a list of the 2,007 articles that have cited the articles published in International Journal of Alzheimer’s Disease.

  • Masha G. Savelieff, Alaina S. DeToma, Jeffrey S. Derrick, and Mi Hee Lim, “The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-beta Species in Alzheimer's Disease,” Accounts of Chemical Research, vol. 47, no. 8, pp. 2475–2482, 2014. View at Publisher · View at Google Scholar
  • R. Nardone, F. Tezzon, Y. Höller, S. Golaszewski, E. Trinka, and F. Brigo, “Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease,” Acta Neurologica Scandinavica, 2014. View at Publisher · View at Google Scholar
  • Eric Siemers, Robert A. Dean, Ronald B. DeMattos, Michael L. Hutton, Kaj Blennow, Leslie M. Shaw, and David M. Holtzman, “Anti-Aβ antibody target engagement: commentary regarding Watt et al. Acta Neuropathol 127:803–810 (2014),” Acta Neuropathologica, 2014. View at Publisher · View at Google Scholar
  • Małgorzata Jurak, Monika Golabek, Lucyna Holysz, and Emil Chibowski, “Properties of Langmuir and solid supported lipid films with sphingomyelin,” Advances in Colloid and Interface Science, 2014. View at Publisher · View at Google Scholar
  • Piotr Lewczuk, “Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment,” Advances in Geriatrics, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Michelle E. Kelly, David Loughrey, Brian A. Lawlor, Ian H. Robertson, Cathal Walsh, and Sabina Brennan, “The Impact of Cognitive Training and Mental Stimulation on Cognitive and Everyday Functioning of Healthy Older Adults: A Systematic Review and Meta-Analysis,” Ageing Research Reviews, 2014. View at Publisher · View at Google Scholar
  • Lawla L.F. Law, Fiona Barnett, Matthew K. Yau, and Marion A. Gray, “Effects of combined cognitive and exercise interventions on cognition in older adults with and without cognitive impairment: A Systematic Review,” Ageing Research Reviews, 2014. View at Publisher · View at Google Scholar
  • Tiago Silva, Joana Reis, José Teixeira, and Fernanda Borges, “Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes,” Ageing Research Reviews, 2014. View at Publisher · View at Google Scholar
  • William E. Mansbach, Ryan A. Mace, and Kristen M. Clark, “Differentiating levels of cognitive functioning: a comparison of the Brief Interview for Mental Status (BIMS) and the Brief Cognitive Assessment Tool (BCAT) in a nursing home sample,” Aging & Mental Health, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Clarissa M. Giebel, Caroline Sutcliffe, and David Challis, “Activities of daily living and quality of life across different stages of dementia: a UK study,” Aging & Mental Health, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Carlos Chiatti, Joseph M. Rimland, Franco Bonfranceschi, Filippo Masera, Silvia Bustacchini, and Laura Cassetta, “The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population,” Aging & Mental Health, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Adham R. Mohamed, Gehan Y. Soliman, Cherine A. Ismail, and Hazem F. Mannaa, “Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats,” Alexandria Journal of Medicine, 2014. View at Publisher · View at Google Scholar
  • Megan K. Herbert, Marjolein B. Aerts, H. Bea Kuiperij, Jurgen A. H. R. Claassen, Petra E. Spies, Rianne A. J. Esselink, Bastiaan R. Bloem, and Marcel M. Verbeek, “Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias,” Alzheimers & Dementia, vol. 10, no. 4, pp. 448–455, 2014. View at Publisher · View at Google Scholar
  • Maria C. Carrillo, Francine Grodstein, Kim Henriksen, Andreas Jeromin, Simon Lovestone, Michelle M. Mielke, Sid O'Bryant, Manual Sarasa, Magnus Sjogren, Holly Soares, Jessica Teeling, Eugenia Trushina, Malcolm Ward, Tim West, Lisa J. Bain, Diana W. Shineman, Michael Weiner, and Howard M. Fillit, “Developing novel blood-based biomarkers for Alzheimer's disease,” Alzheimers & Dementia, vol. 10, no. 1, pp. 109–114, 2014. View at Publisher · View at Google Scholar
  • David A. Drachman, “The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease,” Alzheimers & Dementia, vol. 10, no. 3, pp. 372–380, 2014. View at Publisher · View at Google Scholar
  • Hayk Davtyan, Anahit Ghochikyan, Irina Petrushina, Armine Hovakimyan, Arpine Davtyan, and David H. Cribbs, “The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates,” Alzheimers & Dementia, vol. 10, no. 3, pp. 271–283, 2014. View at Publisher · View at Google Scholar
  • Otto Pedraza, Mariet Allen, Kyle Jennette, Minerva Carrasquillo, Julia Crook, Daniel Serie, V. Shane Pankratz, Ryan Palusak, Thuy Nguyen, Kimberly Malphrus, Li Ma, Gina Bisceglio, Rosebud O. Roberts, John A. Lucas, Robert J. Ivnik, Glenn E. Smith, Neill R. Graff-Radford, Ronald C. Petersen, Steven G. Younkin, and Nilüfer Ertekin-Taner, “Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects,” Alzheimer's & Dementia, vol. 10, no. 2, pp. 205–213, 2014. View at Publisher · View at Google Scholar
  • Konrad Talbot, and Hoau-Yan Wang, “The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease,” Alzheimer's & Dementia, vol. 10, no. 1, pp. S12–S25, 2014. View at Publisher · View at Google Scholar
  • Mick M. Welling, Rob J.A. Nabuurs, and Louise van der Weerd, “Potential role of antimicrobial peptides in the early onset of Alzheimer's disease,” Alzheimer's & Dementia, 2014. View at Publisher · View at Google Scholar
  • Lori A. Daiello, Assawin Gongvatana, Shira Dunsiger, Ronald A. Cohen, and Brian R. Ott, “Association of fish oil supplement use with preservation of brain volume and cognitive function,” Alzheimer's & Dementia, 2014. View at Publisher · View at Google Scholar
  • Timothy C. Durazzo, Niklas Mattsson, and Michael W. Weiner, “Smoking and increased Alzheimer's disease risk: A review of potential mechanisms,” Alzheimer's & Dementia, vol. 10, no. 3, pp. S122–S145, 2014. View at Publisher · View at Google Scholar
  • Massimo S. Fiandaca, Dimitrios Kapogiannis, Mark Mapstone, Adam Boxer, Erez Eitan, Janice B. Schwartz, Erin L. Abner, Ronald C. Petersen, Howard J. Federoff, Bruce L. Miller, and Edward J. Goetzl, “Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study,” Alzheimer's & Dementia, 2014. View at Publisher · View at Google Scholar
  • Galit Weinstein, and Sudha Seshadri, “Circulating biomarkers that predict incident dementia,” Alzheimers Research & Therapy, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar
  • Jamie Toombs, Ross W. Paterson, Jonathan M. Schott, and Henrik Zetterberg, “Amyloid-beta 42 adsorption following serial tube transfer,” Alzheimers Research & Therapy, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar
  • Bengt Winblad, Ana Graf, Marie-Emmanuelle Riviere, Niels Andreasen, and J. Michael Ryan, “Active immunotherapy options for Alzheimer's disease,” Alzheimers Research & Therapy, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar
  • Jeremy H. Toyn, and Michael K. Ahlijanian, “Interpreting Alzheimer's disease clinical trials in light of the effects on amyloid-beta,” Alzheimers Research & Therapy, vol. 6, no. 2, 2014. View at Publisher · View at Google Scholar
  • Sara Santos, and Miguel Castanho, “The Use of Visual Analog Scales to Compare Pain Between Patients With Alzheimer's Disease and Patients Without Any Known Neurodegenerative Disease and Their Caregivers,” American Journal of Alzheimers Disease and Other Dementias, vol. 29, no. 4, pp. 320–325, 2014. View at Publisher · View at Google Scholar
  • Guia Guffanti, Simona Gaudi, James H. Fallon, Janet Sobell, Steven G. Potkin, Carlos Pato, and Fabio Macciardi, “Transposable elements and psychiatric disorders,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014. View at Publisher · View at Google Scholar
  • Qing-Qing Tao, Yi-Min Sun, Zhi-Jun Liu, Wang Ni, Ping Yang, Hong-Lei Li, Shen-Ji Lu, and Zhi-Ying Wu, “A Variant Within FGF1 is Associated With Alzheimer's Disease in the Han Chinese Population,” American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, vol. 165, no. 2, pp. 131–136, 2014. View at Publisher · View at Google Scholar
  • Serena Abbondante, David Baglietto-Vargas, Carlos J. Rodriguez-Ortiz, Tatiana Estrada-Hernandez, Rodrigo Medeiros, and Frank M. LaFerla, “Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes,” American Journal of Pathology, vol. 184, no. 3, pp. 819–826, 2014. View at Publisher · View at Google Scholar
  • Cyrus A. Raji, Kirk I. Erickson, Oscar L. Lopez, Lewis H. Kuller, H. Michael Gach, Paul M. Thompson, Mario Riverol, and James T. Becker, “Regular Fish Consumption and Age-Related Brain Gray Matter Loss,” American Journal of Preventive Medicine, 2014. View at Publisher · View at Google Scholar
  • Antoine Leuzy, Eduardo Rigon Zimmer, Kerstin Heurling, Pedro Rosa-Neto, and Serge Gauthier, “Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issues,” Amyloid, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Donghyuck Bae, Yongjae Kim, Jihye Kim, Yujin Kim, Kyonyeo Oh, Woojin Jun, and Sunoh Kim, “ Neuroprotective effects of Eriobotrya japonica and Salvia miltiorrhiza Bunge in in vitro and in vivo models ,” Animal Cells and Systems, vol. 18, no. 2, pp. 119–134, 2014. View at Publisher · View at Google Scholar
  • Claudia Gatta, Luciana Castaldo, Alessandro Cellerino, Paolo de Girolamo, Carla Lucini, and Livia D’Angelo, “Brain derived neurotrophic factor in the retina of the teleost N. furzeri,” Annals of Anatomy - Anatomischer Anzeiger, 2014. View at Publisher · View at Google Scholar
  • Daniel Cardinali, Daniel Vigo, Natividad Olivar, María Vidal, and Luis Brusco, “Melatonin Therapy in Patients with Alzheimer’s Disease,” Antioxidants, vol. 3, no. 2, pp. 245–277, 2014. View at Publisher · View at Google Scholar
  • Kyrana Tsapkini, Constantine Frangakis, Yessenia Gomez, Cameron Davis, and Argye E. Hillis, “Augmentation of spelling therapy with transcranial direct current stimulation in primary progressive aphasia: Preliminary results and challenges,” Aphasiology, vol. 28, no. 8-9, pp. 1112–1130, 2014. View at Publisher · View at Google Scholar
  • Tushar Kanti Das, Mas Rina Wati, and Kaneez Fatima-Shad, “Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease,” Archives of Neuroscience, vol. 2, no. 3, 2014. View at Publisher · View at Google Scholar
  • Soumyabrata Munshi, Vineet Kumar Khemka, Kalpita Banerjee, and Sasanka Chakrabarti, “Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease,” Asian Journal of Neuroscience, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Lakshmi narayanan Kota, Srikala Bharath, Meera Purushottam, Pradip Paul, Palanimuthu Thangaraju Sivakumar, Mathew Varghese, and Sanjeev Jain, “Reduced telomere length in subjects with dementia and diabetes mellitus type 2 is independent of Apolipoprotein E4 genotype,” Asian Journal of Psychiatry, 2014. View at Publisher · View at Google Scholar
  • Daijun Ling, Martha Magallanes, and Paul M. Salvaterra, “Accumulation of amyloid-like A beta(1-42) in AEL (autophagy-endosomal-lysosomal) vesicles: potential implications for plaque biogenesis,” Asn Neuro, vol. 6, no. 2, 2014. View at Publisher · View at Google Scholar
  • Anne-Sophie Nicot, Francesca Lo Verso, Francesca Ratti, Fanny Pilot-Storck, Nathalie Streichenberger, Marco Sandri, Laurent Schaeffer, and Evelyne Goillot, “Phosphorylation of NBR1 by GSK3 modulates protein aggregation,” Autophagy, vol. 10, no. 6, pp. 1036–1053, 2014. View at Publisher · View at Google Scholar
  • Matteo De Marco, Peter J. Clough, Charlotte E. Dyer, Rebecca V. Vince, Jennifer S. Waby, Adrian W. Midgley, and Annalena Venneri, “Apolipoprotein E ε4 Allele Modulates the Immediate Impact of Acute Exercise on Prefrontal Function,” Behavior Genetics, 2014. View at Publisher · View at Google Scholar
  • Adi Shruster, and Daniel Offen, “Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease,” Behavioural Brain Research, vol. 261, pp. 193–201, 2014. View at Publisher · View at Google Scholar
  • Gloria Blazquez, Toni Canete, Adolf Tobena, Lydia Gimenez-Llort, and Alberto Fernandez-Teruel, “Cognitive and emotional profiles of aged Alzheimer's disease (3 x TgAD) mice: Effects of environmental enrichment and sexual dimorphism,” Behavioural Brain Research, vol. 268, pp. 185–201, 2014. View at Publisher · View at Google Scholar
  • Virginia Torres-Lista, Cristina Parrado-Fernandez, Ismael Alvarez-Monton, Javier Frontinan-Rubio, Mario Duran-Prado, Juan Ramon Peinado, Bjorn Johansson, Francisco Javier Alcain, and Lydia Gimenez-Llort, “Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice,” Behavioural Brain Research, vol. 271, pp. 140–146, 2014. View at Publisher · View at Google Scholar
  • Pınar Kurt, Derya Durusu Emek-Savaş, Kübra Batum, Bilge Turp, Bahar Güntekin, Sibel Karşıdağ, and Görsev Gülmen Yener, “Patients with Mild Cognitive Impairment Display Reduced Auditory Event-Related Delta Oscillatory Responses,” Behavioural Neurology, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Virginia Torres-Lista, and Lydia Gimenez-Llort, “Persistence of behaviours in the Forced Swim Test in 3xTg-AD mice at advanced stages of disease,” Behavioural Processes, vol. 106, pp. 118–121, 2014. View at Publisher · View at Google Scholar
  • Balu Chakravarthy, Shingo Ito, Trevor Atkinson, Chantal Gaudet, Michel Ménard, Leslie Brown, and James Whitfield, “Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer’s disease brain,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Ravichandran Yesuvadian, Janarthanan Krishnamoorthy, Ayyalusamy Ramamoorthy, and Anirban Bhunia, “w Potent gamma-secretase inhibitors/modulators interact with amyloid-beta fibrils but do not inhibit fibrillation: A high-resolution NMR study,” Biochemical and Biophysical Research Communications, vol. 447, no. 4, pp. 590–595, 2014. View at Publisher · View at Google Scholar
  • Judith J. Mittag, Silvia Milani, Dominic M. Walsh, Joachim O. Rädler, and Jennifer J. McManus, “Simultaneous measurement of a range of particle sizes during Aβ1-42 fibrillogenesis quantified using fluorescence correlation spectroscopy,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Gabriele Loers, Yi-Fang Cui, Irmgard Neumaier, Melitta Schachner, and Arne Skerra, “A Fab fragment directed against the neural cell adhesion molecule L1 enhances functional recovery after injury of the adult mouse spinal cord,” Biochemical Journal, vol. 460, pp. 437–446, 2014. View at Publisher · View at Google Scholar
  • John E. Morley, and Susan A. Farr, “The role of amyloid-beta in the regulation of memory,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Fernando Goni, “Immunotherapy for Alzheimer's disease,” Biochemical Pharmacology, vol. 88, no. 4, pp. 499–507, 2014. View at Publisher · View at Google Scholar
  • Kira Irving Mosher, and Tony Wyss-Coray, “Microglial Dysfunction in Brain Aging and Alzheimer's Disease,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Miguel Medina, and Jesus Avila, “New perspectives on the role of tau in Alzheimer's disease. Implications for therapy,” Biochemical Pharmacology, vol. 88, no. 4, pp. 540–547, 2014. View at Publisher · View at Google Scholar
  • Christos E. Zois, Elena Favaro, and Adrian L. Harris, “Glycogen metabolism in cancer,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Joo In Jung, Yong Ran, Pedro E. Cruz, Awilda M. Rosario, Thomas B. Ladd, Thomas L. Kukar, Edward H. Koo, Kevin M. Felsenstein, and Todd E. Golde, “Complex Relationships between Substrate Sequence and Sensitivity to Alterations in gamma-Secretase Processivity Induced by gamma-Secretase Modulators,” Biochemistry, vol. 53, no. 12, pp. 1947–1957, 2014. View at Publisher · View at Google Scholar
  • Jian Xiong, Carol A. Roach, Olayinka O. Oshokoya, Robert P. Schroell, Rauta A. Yakubu, Michael K. Eagleburger, and Jason W. Cooley, “Role of Bilayer Characteristics on the Structural Fate of A beta(1-40) and A beta(25-40),” Biochemistry, vol. 53, no. 18, pp. 3004–3011, 2014. View at Publisher · View at Google Scholar
  • Coralie Di Scala, Henri Chahinian, Nouara Yahi, Nicolas Garmy, and Jacques Fantini, “Interaction of Alzheimer’s beta-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation,” Biochemistry, pp. 140707143757007, 2014. View at Publisher · View at Google Scholar
  • E. E. Dubinina, L. V. Schedrina, N. G. Neznanov, N. M. Zalutskaya, and D. V. Zakharchenko, “Oxidative stress and its effect on cell functional activity in Alzheimer’s disease,” Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, vol. 8, no. 3, pp. 181–191, 2014. View at Publisher · View at Google Scholar
  • Moutusi Manna, Tomasz Rog, and Ilpo Vattulainen, “The challenges of understanding glycolipid functions: An open outlook based on molecular simulations,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014. View at Publisher · View at Google Scholar
  • Marco Diociaiuti, Gianfranco Macchia, Silvia Paradisi, Claudio Frank, Serena Camerini, Pietro Chistolini, Maria Cristina Gaudiano, Tamara Corinna Petrucci, and Fiorella Malchiodi-Albedi, “Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014. View at Publisher · View at Google Scholar
  • Hisham Qosa, Harry LeVine, Jeffrey N. Keller, and Amal Kaddoumi, “Mixed oligomers and monomeric Amyloid-β disrupts endothelial cells integrity and reduces monomeric amyloid-β transport across hCMEC/D3 cell line as an in vitro blood-brain barrier model,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014. View at Publisher · View at Google Scholar
  • Marijke De Bock, Elke Decrock, Nan Wang, Mélissa Bol, Mathieu Vinken, Geert Bultynck, and Luc Leybaert, “The dual face of connexin-based astroglial Ca2+ communication: A key player in brain physiology and a prime target in pathology,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014. View at Publisher · View at Google Scholar
  • Mark D. Turner, Belinda Nedjai, Tara Hurst, and Daniel J. Pennington, “Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014. View at Publisher · View at Google Scholar
  • S. J. Annesley, S. Chen, L. M. Francione, O. Sanislav, A. J. Chavan, C. Farah, S. W. De Piazza, C. L. Storey, J. Ilievska, S. G. Fernando, P. K. Smith, and S. T. Lay, “Dictyostelium, a microbial model for brain disease,” Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 4, pp. 1413–1432, 2014. View at Publisher · View at Google Scholar
  • Wen Fu, and Jack H. Jhamandas, “Role of astrocytic glycolytic metabolism in Alzheimer’s disease pathogenesis,” Biogerontology, 2014. View at Publisher · View at Google Scholar
  • Emőke Borbély, János Horváth, Szabina Furdan, Zsolt Bozsó, Botond Penke, and Lívia Fülöp, “ Simultaneous Changes of Spatial Memory and Spine Density after Intrahippocampal Administration of Fibrillar A β 1–42 to the Rat Brain ,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Ying Li, Meng-Shan Tan, Teng Jiang, and Lan Tan, “Microglia in Alzheimer’s Disease,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Gan-lin Zhang, Xiao Zhang, Xiao-min Wang, and Jin-Ping Li, “Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s Disease,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Elisabet Ortiz-Tudela, Antonio Martinez-Nicolas, Carmen Díaz-Mardomingo, Sara García-Herranz, Inmaculada Pereda-Pérez, Azucena Valencia, Herminia Peraita, César Venero, Juan Antonio Madrid, and Maria Angeles Rol, “The Characterization of Biological Rhythms in Mild Cognitive Impairment,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Hamid Reza Sadeghnia, Taghi Ghorbani Hesari, Seyed Mohsen Mortazavian, Seyed Hadi Mousavi, Zahra Tayarani-Najaran, and Ahmad Ghorbani, “ Viola tricolor Induces Apoptosis in Cancer Cells and Exhibits Antiangiogenic Activity on Chicken Chorioallantoic Membrane ,” BioMed Research International, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Anmu Xie, Jing Gao, Lin Xu, and Dongmei Meng, “Shared Mechanisms of Neurodegeneration in Alzheimer’s Disease and Parkinson’s Disease,” BioMed Research International, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Hung-Jin Huang, Cheng-Chun Lee, and Calvin Yu-Chian Chen, “In Silico Design of BACE1 Inhibitor for Alzheimer’s Disease by Traditional Chinese Medicine,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Alessandro Fulgenzi, Daniele Vietti, and Maria Elena Ferrero, “Aluminium Involvement in Neurotoxicity,” BioMed Research International, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Perani Daniela, Schillaci Orazio, Padovani Alessandro, Nobili Flavio Mariano, Iaccarino Leonardo, Della Rosa Pasquale Anthony, Frisoni Giovanni, and Caltagirone Carlo, “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis,” BioMed Research International, vol. 2014, pp. 1–22, 2014. View at Publisher · View at Google Scholar
  • Liara Rizzi, Idiane Rosset, and Matheus Roriz-Cruz, “Global Epidemiology of Dementia: Alzheimer’s and Vascular Types,” BioMed Research International, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Saeed Samarghandian, Mohsen Azimi-Nezhad, and Fariborz Samini, “Ameliorative Effect of Saffron Aqueous Extract on Hyperglycemia, Hyperlipidemia, and Oxidative Stress on Diabetic Encephalopathy in Streptozotocin Induced Experimental Diabetes Mellitus,” BioMed Research International, vol. 2014, pp. 1–12, 2014. View at Publisher · View at Google Scholar
  • James G. McLarnon, “Correlated Inflammatory Responses and Neurodegeneration in Peptide-Injected Animal Models of Alzheimer’s Disease,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Martin Gorges, Hans-Peter Müller, Albert C. Ludolph, Volker Rasche, and Jan Kassubek, “Intrinsic Functional Connectivity Networks in Healthy Elderly Subjects: A Multiparametric Approach with Structural Connectivity Analysis,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Fernando C. Ortiz, Cecilia Vergara, and Julio Alcayaga, “Micromolar copper modifies electrical properties and spontaneous discharges of nodose ganglion neurons in vitro,” Biometals, vol. 27, no. 1, pp. 45–52, 2014. View at Publisher · View at Google Scholar
  • Rosanna Squitti, Mariacristina Siotto, Serena Bucossi, and Renato Polimanti, “In silico investigation of the ATP7B gene: insights from functional prediction of non-synonymous substitution to protein structure,” Biometals, vol. 27, no. 1, pp. 53–64, 2014. View at Publisher · View at Google Scholar
  • Marc Pudlo, Vincent Luzet, Lhassane Ismaili, Isabelle Tomassoli, Anne Iutzeler, and Bernard Refouvelet, “Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease,” Bioorganic & Medicinal Chemistry, vol. 22, no. 8, pp. 2496–2507, 2014. View at Publisher · View at Google Scholar
  • Fouad H. Darras, Sarah Wehle, Guozheng Huang, Christoph A. Sotriffer, and Michael Decker, “Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with “inverted” binding mode,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Hayrettin Ozan Gulcan, Serdar Unlu, İlker Esiringu, Tugba Ercetin, Yasemin Sahin, Demet Oz, and Mustafa Fethi Sahin, “Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Alexey Yu. Sukhorukov, Anilkumar C. Nirvanappa, Jagadish Swamy, Sema L. Ioffe, Shivananju Nanjunda Swamy, Basappa Basappa, and Kanchugarakoppal S. Rangappa, “Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase,” Bioorganic & Medicinal Chemistry Letters, vol. 24, no. 15, pp. 3618–3621, 2014. View at Publisher · View at Google Scholar
  • Kazuma Murakami, “Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer’s disease,” Bioscience, Biotechnology, and Biochemistry, vol. 78, no. 8, pp. 1293–1305, 2014. View at Publisher · View at Google Scholar
  • Rimpi Khurana, Vinod Kumar Verma, Abdul Rawoof, Shrish Tiwari, Rekha A. Nair, Ganesh Mahidhara, Mohammed M. Idris, Alan R. Clarke, and Lekha Dinesh Kumar, “OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer,” Bmc Bioinformatics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Maura Barbisin, Silvia Vanni, Ann-Christin Schmaedicke, Judith Montag, Dirk Motzkus, Lennart Opitz, Gabriela Salinas-Riester, and Giuseppe Legname, “Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques,” Bmc Genomics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Richard Lathe, Alexandra Sapronova, and Yuri Kotelevtsev, “Atherosclerosis and Alzheimer - diseases with a common cause? Inflammation, oxysterols, vasculature,” Bmc Geriatrics, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Marissa K. Constand, Joy C. MacDermid, Vanina Dal Bello-Haas, and Mary Law, “Scoping review of patient-centered care approaches in healthcare,” Bmc Health Services Research, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Tae Sung Lim, Jun Young Choi, Sun Ah Park, Young Chul Youn, Hyun Young Lee, Byung Gon Kim, In Soo Joo, Kyoon Huh, and So Young Moon, “Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers,” Bmc Neurology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Ben J. Smith, Suha Ali, and Henry Quach, “Public knowledge and beliefs about dementia risk reduction: a national survey of Australians,” Bmc Public Health, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Laura Caberlotto, and Tp Thanh-Phuong Nguyen, “A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy,” Bmc Systems Biology, vol. 8, 2014. View at Publisher · View at Google Scholar
  • Isabel Lastres-Becker, Nadia G. Innamorato, Tomasz Jaworski, Alberto Rabano, Sebastian Kuegler, Fred Van Leuven, and Antonio Cuadrado, “Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis,” Brain, vol. 137, pp. 78–91, 2014. View at Publisher · View at Google Scholar
  • J. Nyberg, M. A. I. Aberg, L. Schioler, M. Nilsson, A. Wallin, K. Toren, and H. G. Kuhn, “Cardiovascular and cognitive fitness at age 18 and risk of early-onset dementia,” Brain, 2014. View at Publisher · View at Google Scholar
  • Paul M. Thompson, Steven G. Potkin, Lars Bertram, Lindsay A. Farrer, Tatiana M. Foroud, Robert C. Green, Xiaolan Hu, Matthew J. Huentelman, Sungeun Kim, John S. K. Kauwe, Qingqin Li, Enchi Liu, Fabio Macciardi, Jason H. Moore, Leanne Munsie, Kwangsik Nho, Vijay K. Ramanan, Shannon L. Risacher, David J. Stone, Shanker Swaminathan, Arthur W. Toga, Michael W. Weiner, and Andrew J. Saykin, “Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 183–207, 2014. View at Publisher · View at Google Scholar
  • Florence F. Roussotte, Madelaine Daianu, Neda Jahanshad, and Cassandra D. Leonardo, “Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 217–233, 2014. View at Publisher · View at Google Scholar
  • Jesse Brown, “Imaging markers of structural and functional brain changes that precede cognitive symptoms in risk for Alzheimer's disease,” Brain Imaging and Behavior, vol. 8, no. 2, pp. 251–261, 2014. View at Publisher · View at Google Scholar
  • Mark P. Burns, Sonali Pal-Ghosh, Gauri Tadvalkar, Nicole G. Hokenbury, Mary Ann Stepp, and Alan I. Faden, “Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury,” Brain Research, vol. 1560, pp. 73–82, 2014. View at Publisher · View at Google Scholar